Bokhari

Bokhari v. Torrent Pharmaceuticals Limited

Good Law
United States District Court, Northern District of CaliforniaApril 6, 20204:19-cv-08045California980 words

Opinion

trial_court Opinion

] HEREBY CERTIFY that the above : . foregoing is a true and correct COPY □

UNITED STATES JUDICIAL PANEL — UNITED STATES DISTRICT COUR

on DISTRICT OF NEWJERSEY

MULTIDISTRICT LITIGATION AMT. WARSHACLERK □

Biya . iy IN RE: VALSARTAN, LOSARTAN, AND IRBESARTAN — eee PRODUCTS LIABILITY LITIGATION MDL No. 2875

TRANSFER ORDER |

Before the Panel:’ Plaintiff in the Northern District of California action listed on Schedule A (Bokhari) moves under Panel Rule 7.1 to vacate the order conditionally transferring Bokhari to MDL No. 2875. Defendants Torrent Pharmaceuticals Limited, Torrent Pharma, Inc., Hetero Labs Ltd., Hetero USA, Inc., Camber Pharmaceuticals, Inc. (Camber), and CVS Pharmacy Inc. oppose the motion and support transfer. —

After considering the argument of counsel, we find that this action involves common questions of fact with the actions transferred to MDL No. 2875, and that transfer under 28 U.S.C. § 1407 will serve the convenience of the parties and witnesses and promote the just and efficient conduct of the litigation. Like…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.